Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Document › Details

Agilent Technologies Inc.. (10/29/18). "Press Release: Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience's S-1 Registration Statement". Santa Clara, CA.

Region Region United States (USA)
Organisations Organisation Agilent Technologies Inc. (NYSE: A)
  Organisation 2 Twist Bioscience Corporation (Nasdaq: TWST)
  Group Twist Bioscience (Group)
Product Product oligo synthesis
Persons Person LeProust, Emily M. (Twist Bioscience 2013– CEO + Co-Founder before Agilent Director Genomics Application Development)
  Person 2 Notaney, Stefanie (Agilent 201801)

Agilent Technologies Inc. (NYSE: A) today announced that it sent a letter to the Division of Corporation Finance of the U.S. Securities and Exchange Commission (SEC) regarding misstatements in the S-1 Registration Statement filed by Twist Bioscience Corp.

The letter informs the SEC that "Twist's S-1 Fails to Disclose that Twist CEO Emily Leproust Formed Twist While an Employee at Agilent, and Became its CEO 17 Months Prior to Resigning from Agilent." The letter also informs the SEC that "Twist's S-1 Fails to Disclose the Material Fact that its CEO Emily Leproust and Other Twist Employees Took and Retained Hundreds of Confidential Documents Containing Agilent's Trade Secrets and Proprietary Information."

Ms. Leproust admitted under oath that she secretly became Twist's CEO 17 months prior to leaving Agilent. Agilent's Proposed Second Amended Complaint (accessible here) describes in detail Agilent's allegations that during that time, Ms. Leproust raised money to start a competitive company that would misappropriate Agilent's innovations of the past 20 years, poach Agilent's employees, and compete in the same markets with the same basic technology—all while owing a statutory duty of loyalty to Agilent.

The full text of Agilent's letter to the SEC is available here. [  ]

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 14,500 people worldwide. Information about Agilent is available at

Media Contact

Stefanie Notaney
+1 408 345 8955

Record changed: 2023-06-05


Picture Bionter Seeing Things witzh EVE the Particle Counter 650x200px

More documents for Agilent (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top